Brian Curwain
Dr B. P. Curwain, MRPharmS
Recent stories
Patients’ ethical framework should take precedenceSubscription
I note there is concern over the proposed changes in the conscience clause suggested by the General Pharmaceutical Council (The Pharmaceutical Journal online, 22 December 201
No guarantee of quality with unlicensed vitamin D productsSubscription
Colin Michie’s article on the risks of vitamin D self supplementation makes many useful points, including the risks associated with excess vitamin D (Clinical Pharmacist, 2016;8:131). But there is one major issue that was not highlighted: the vast majority of vitamin D products sold through pharmacies and elsewhere ar
Absolute levels of risk are needed to make informed decisions for patientsSubscription
Renal adverse effects of proton pump inhibitors (PPIs) were described in your research briefing ‘Proton pump inhibitors linked with chronic kidney disease’ (Clinical Pharmacist
Serious side effect with quinolone antibioticsSubscription
New alcohol guidelines are not realisticSubscription
Foods that cause blood glucose spikeSubscription
Using licensed productsSubscription
Water intake affects uric acid excretionSubscription
E-cigarettes: proceed with cautionSubscription
Decriminalisation will change the way we workSubscription
